{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:45:10Z","timestamp":1786243510419,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clineuro.2026.109523","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:01:50Z","timestamp":1779951710000},"page":"109523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of concurrent cancers on survival of patients with newly diagnosed glioblastoma"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-2721","authenticated-orcid":false,"given":"Bujung","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Tsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Moros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kipele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8439-1189","authenticated-orcid":false,"given":"Hans E.","family":"Heissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Ziegenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Shiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2026.109523_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2026.109523_bib2","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00432-021-03596-5","article-title":"Patterns of glioblastoma treatment and survival over 16-years period: pooled data from the German Cancer Registries","volume":"147","author":"Efremov","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/annonc\/mdx106","article-title":"Glioblastoma targeted therapy: updated approaches from recent biological insights","volume":"28","author":"Touat","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib4","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.10595","article-title":"High-grade gliomas in patients with prior systemic malignancies","volume":"94","author":"Maluf","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2026.109523_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000527437","article-title":"Primary malignant brain tumors following systemic malignancies: a population-based analysis","volume":"56","author":"Wang","year":"2022","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clineuro.2026.109523_bib6","first-page":"386","article-title":"Second primary cancers in long-term survivors of glioblastoma","volume":"6","author":"Kim","year":"2019","journal-title":"Neurooncol Pract."},{"key":"10.1016\/j.clineuro.2026.109523_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1075-122X.2006.00307.x","article-title":"Multicentric glioblastoma multiforme in a patient with BRCA-1 invasive breast cancer","volume":"12","author":"Elmariah","year":"2006","journal-title":"Breast J."},{"key":"10.1016\/j.clineuro.2026.109523_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.asjsur.2012.06.007","article-title":"High-grade glioma in a patient with breast cancer","volume":"37","author":"Chang","year":"2014","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.clineuro.2026.109523_bib9","first-page":"1378","article-title":"Breast cancer and high-grade glioma: link or coincidence","volume":"20","author":"Hanalioglu","year":"2015","journal-title":"J. BUON"},{"key":"10.1016\/j.clineuro.2026.109523_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/030089160509100309","article-title":"Glioblastoma multiforme and breast cancer: report on 11 cases and clinico-pathological remarks","volume":"91","author":"Piccirilli","year":"2005","journal-title":"Tumori"},{"key":"10.1016\/j.clineuro.2026.109523_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10143-016-0733-8","article-title":"Secondary glioma following acute lymphocytic leukemia: therapeutic implications","volume":"40","author":"Yamanaka","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.clineuro.2026.109523_bib12","article-title":"Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.clineuro.2026.109523_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-017-2512-y","article-title":"Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients","volume":"134","author":"Zacharia","year":"2017","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2013.01.002","article-title":"Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population-based study under the Danish Breast Cancer Cooperative Group (DBCG)","volume":"106","author":"Grantzau","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/JCO.2009.24.8062","article-title":"Second malignant neoplasms in survivors of pediatric Hodgkin\u2019s lymphoma treated with low-dose radiation and chemotherapy","volume":"28","author":"O\u2019Brien","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-021-02307-1","article-title":"Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin","volume":"142","author":"F\u00f6rster","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2026.109523_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s41016-022-00312-1","article-title":"Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors","volume":"8","author":"Wang","year":"2022","journal-title":"Chin. Neurosurg. J."},{"key":"10.1016\/j.clineuro.2026.109523_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2026.109523_bib19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2026.109523_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2026.109523_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-018-03028-4","article-title":"Management and survival trends for adult patients with malignant gliomas in the setting of multiple primary tumors: a population-based analysis","volume":"141","author":"Nguyen","year":"2019","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/00207454.2018.1538989","article-title":"Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study","volume":"129","author":"Al-Husseini","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.clineuro.2026.109523_bib25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2026.109523_bib26","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-03-0384","article-title":"Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide","volume":"10","author":"Hegi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clineuro.2026.109523_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11060-009-0031-1","article-title":"Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods","volume":"97","author":"Karayan-Tapon","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2026.109523_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ijc.27385","article-title":"German Glioma Network, Predictive impact of MGMT promoter methylation in glioblastoma of the elderly","volume":"131","author":"Reifenberger","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clineuro.2026.109523_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2026.109523_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00701-024-06300-x","article-title":"MGMT methylation and its prognostic significance in inoperable IDH\u2011wildtype glioblastoma: the MGMT\u2011GBM study","volume":"166","author":"Ghimire","year":"2024","journal-title":"Acta Neurochir."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726002155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726002155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:23:14Z","timestamp":1786242194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0303846726002155"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109523","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of concurrent cancers on survival of patients with newly diagnosed glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109523"}}